This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Evidence from epidemiological data and animal experiments implicate the placenta as the origin of pre-eclampsia. Poor placental perfusion causes the release of blood borne products from the fetoplacental unit which result in endothelial cell dysfunction. There is an increased sensitivity to normal circulating pressor agents, increased intracellular coagulation and increased fluid loss from the intravascular compartment.

Evidence for the role of the placenta in pre-eclampsia comes from many observations including:

  • pre-eclampsia is uniquely a disease of pregnancy - by 6 months post partum, the observed pathophysiological changes have reverted to normal
  • pre-eclampsia may occur in abdominal pregnancy - so the uterus is unlikely to be involved
  • pre-eclampsia may occur with a hydatidiform mole - so a foetus is not always necessary

Causes of a poorly perfused placenta include:

  • abnormal trophoblast implantation and spiral artery atherosis
  • microvascular disease - pre-existing hypertension, diabetes, collagen vascular diseases
  • a large placenta - multiple pregnancy, hydatidiform mole, a fetus with a hydropic placenta

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.